author-photo

Douglas Earl Laux

University of Iowa

11

Papers

10

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

High-specific-activity 131iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma.

2021 Future Oncology
Show All
- Source
- Cite
- Save
Citations (1)
423 Safety and preliminary efficacy of intratumoral cavrotolimod (AST-008), a spherical nucleic acid TLR9 agonist, in combination with pembrolizumab in patients with advanced solid tumors

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
A phase Ib study of combination of avelumab and taxane-based chemotherapy in platinum refractory or ineligible metastatic urothelial cancer (AVETAX study).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
423 Safety and preliminary efficacy of intratumoral cavrotolimod (AST-008), a spherical nucleic acid TLR9 agonist, in combination with pembrolizumab in patients with advanced solid tumors

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma

2020 Clinical Case Reports
Show All
- Source
- Cite
- Save
Citations (0)
Effects of GC4419 (avasopasem manganese) on chronic kidney disease in head and neck cancer patients treated with radiation and cisplatin.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)